The largest randomised trial to examine the effectiveness of two surgical interventions for treating acute malignant bowel obstruction, a common symptom of patients with colorectal cancer, suggests ...

<0> Cook MedicalCaitlin Wenz, 812-339-2235, ext. 4245Specialist, Public Relations,orRacepoint Group, Inc.Sally Bain, 781-487-4647 </0> The U.S. Food and Drug Administration (FDA) has granted 510(k) ...

The high incidence of colorectal cancer and the high number of patients presenting with a bowel obstruction (7–29% of patients with colorectal cancer) requires the development of novel techniques to ...

Cook Medical has announced it has received FDA clearance for its Evolution colonic controlled-release stent, according to a news release. The new stent is designed to be used to palliate uncomfortable ...

Patients presenting with acute malignant colonic obstruction often undergo emergency surgery, although this is associated with significant mortality and morbidity. An alternative approach is to use a ...

Association of genetic variants in plastin family genes with tumor recurrence in stage II/III colon cancer. This is an ASCO Meeting Abstract from the 2012 ASCO Annual Meeting I. This abstract does not ...

The American Cancer Society (Atlanta) estimates that more than 103,000 new cases of colon cancer will be reported in 2012 in the U.S. alone. Some patients with colon cancer may experience colonic ...

Phase II study of the early start of chemotherapy after excision of primary colorectal cancer with distant metastases (Pearl Star 02). Effect of first-line molecular targeted agents on the efficacy of ...

The scale rates three sections of the colon, right (cecum and ascending colon), mid-colon (transverse and descending) and rectosigmoid, on a five-point scale (0–4). Total score (0–14) is obtained by ...